GMAB-D31N/3pRNA (Gennao/Yale university)

N/A

Report date: 2025/03/20 15:05:04

Base Information

Drug NameGMAB-D31N/3pRNA (Gennao/Yale university)
Drug Alias Nameanti-ENT2 mAb/RIG-I agonist (Gennao/Yale university)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate
Mechanisms of ActionEquilibrative Nucleoside Transporter 2 modulatorsRetinoic acid-inducible gene I stimulants
TargetsEquilibrative Nucleoside Transporter 2Retinoic acid-inducible gene I
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesGennao BioYale University
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A